Treatment with Rituximab in a Patient with Refractory Felty Syndrome and Low Rheumatoid Arthritis Disease Activity: A Case Report
Journal of Rheumatic Diseases
;
: 35-39, 2014.
Article
in Korean
| WPRIM
| ID: wpr-109420
ABSTRACT
Felty syndrome (FS) is a rare manifestation in rheumatoid arthritis (RA) characterized by neutropenia and splenomegaly. Treatment for FS is not well established because there has been no randomized controlled study. A few recent reports found rituximab effective in patients with refractory FS. According to those reports, most patients with RA and FS had active arthritis. Here we report a case of a patient with glucocorticoid dependent and disease-modifying anti-rheumatic drugs (DMARDs) refractory FS and quiescent RA who was successfully treated with rituximab.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Arthritis
/
Arthritis, Rheumatoid
/
Splenomegaly
/
Antirheumatic Agents
/
Felty Syndrome
/
Rituximab
/
Neutropenia
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
Korean
Journal:
Journal of Rheumatic Diseases
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS